These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 12638212

  • 1. [Etidronate].
    Inui K, Takaoka K.
    Nihon Rinsho; 2003 Feb; 61(2):226-30. PubMed ID: 12638212
    [Abstract] [Full Text] [Related]

  • 2. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
    Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ.
    N Engl J Med; 1990 Jul 12; 323(2):73-9. PubMed ID: 2113611
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H, Risedronate Phase III Research Group.
    Osteoporos Int; 2002 Dec 12; 13(12):971-9. PubMed ID: 12459940
    [Abstract] [Full Text] [Related]

  • 4. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
    Storm T, Thamsborg G, Steiniche T, Genant HK, Sørensen OH.
    N Engl J Med; 1990 May 03; 322(18):1265-71. PubMed ID: 2109197
    [Abstract] [Full Text] [Related]

  • 5. Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.
    Miller PD.
    Br J Clin Pract; 1996 May 03; 50(1):23-31. PubMed ID: 8729598
    [Abstract] [Full Text] [Related]

  • 6. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T, Kollerup G, Thamsborg G, Genant HK, Sørensen OH.
    J Rheumatol; 1996 Sep 03; 23(9):1560-4. PubMed ID: 8877926
    [Abstract] [Full Text] [Related]

  • 7. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ, Ioannidis G, Adachi JD, Bensen WG, Bianchi F, Cividino A, Gordon M, Kaminska E, Scocchia T, Petrie A, Stephenson GF, Goldsmith CH.
    J Rheumatol; 1999 Jul 03; 26(7):1545-9. PubMed ID: 10405943
    [Abstract] [Full Text] [Related]

  • 8. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S, Ohosone Y, Suwa A, Yasuoka H, Nojima T, Fujii T, Kuwana M, Nakamura K, Mimori T, Hirakata M.
    J Rheumatol; 2003 Dec 03; 30(12):2673-9. PubMed ID: 14719212
    [Abstract] [Full Text] [Related]

  • 9. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T, Maekawa S, Morinobu S, Morinobu A, Koshiba M, Yamauchi M, Sugimoto T, Kumagai S.
    Ryumachi; 2002 Aug 03; 42(4):666-75. PubMed ID: 12355861
    [Abstract] [Full Text] [Related]

  • 10. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ, Naganathan V, Barton I, Grauer A.
    J Bone Miner Res; 2004 Feb 03; 19(2):323-9. PubMed ID: 14969403
    [Abstract] [Full Text] [Related]

  • 11. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
    Adachi JD, Roux C, Pitt PI, Cooper C, Moniz C, Dequeker J, Ioannidis G, Cawley MI, Jenkins EA, Walker-Bone KE, Pack S, Stephenson GF, Laan RF, Brown J, Geusens P.
    J Rheumatol; 2000 Oct 03; 27(10):2424-31. PubMed ID: 11036840
    [Abstract] [Full Text] [Related]

  • 12. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S, Takada T, Katsuki Y, Kimura N, Kaneko Y, Suwa A, Hirakata M, Kuwana M.
    J Rheumatol; 2008 Jan 03; 35(1):142-6. PubMed ID: 18050368
    [Abstract] [Full Text] [Related]

  • 13. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K, Yamamoto T, Sawada K, Ohmichi M, Tasaka K, Murata Y.
    Arch Gynecol Obstet; 2003 Jun 03; 268(2):105-6. PubMed ID: 12768299
    [Abstract] [Full Text] [Related]

  • 14. A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.
    Kushida K, Fukunaga M, Kishimoto H, Shiraki M, Itabashi A, Inoue T, Kaneda K, Morii H, Nawata H, Yamamoto K, Ohashi Y, Orimo H.
    J Bone Miner Metab; 2004 Jun 03; 22(5):469-78. PubMed ID: 15316868
    [Abstract] [Full Text] [Related]

  • 15. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP.
    Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222
    [Abstract] [Full Text] [Related]

  • 16. Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
    Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH.
    Am J Med; 1997 Dec 13; 103(6):468-76. PubMed ID: 9428829
    [Abstract] [Full Text] [Related]

  • 17. Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis.
    Guañabens N, Parés A, Ros I, Alvarez L, Pons F, Caballería L, Monegal A, Martínez de Osaba MJ, Roca M, Peris P, Rodés J.
    Am J Gastroenterol; 2003 Oct 13; 98(10):2268-74. PubMed ID: 14572578
    [Abstract] [Full Text] [Related]

  • 18. [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
    Kishimoto H.
    Nihon Rinsho; 1998 Jun 13; 56(6):1531-6. PubMed ID: 9648477
    [Abstract] [Full Text] [Related]

  • 19. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
    Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA.
    N Engl J Med; 1997 Aug 07; 337(6):382-7. PubMed ID: 9241127
    [Abstract] [Full Text] [Related]

  • 20. [Combination of intermittent cyclical etidronate and hormone replacement therapy for postmenopausal osteoporosis].
    Ohta H.
    Clin Calcium; 2002 Jul 07; 12(7):937-43. PubMed ID: 15775385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.